
QIAGEN and Incyte Partner to Develop NGS Diagnostic Panel for Rare Blood Cancers
VENLO, Netherlands & WILMINGTON, DE — QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) and Incyte (Nasdaq: INCY) have announced a global collaboration to create a next-generation sequencing (NGS) diagnostic …
QIAGEN and Incyte Partner to Develop NGS Diagnostic Panel for Rare Blood Cancers Read More